Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of the Egyptian National Cancer Institute. 1997; 9 (1): 21-29
em Inglês | IMEMR | ID: emr-106394

RESUMO

This study was a retrospective analysis of 60 patients with pathologically documented testicular seminoma. The group comprised 21 patients with stage I disease, 17 stage IIa, 17 stage IIb and IIc and five stage III. Cryptorchidism was reported in nine patients and elevated beta subunit of human chorionic gonadotrophin [BHCG] in six. All stage I and IIa patients were treated with radiotherapy alone and reported a five year relapse free actuarial survival rate [RFS] of 93%. Six of stage IIb and IIc patients received radiotherapy and chemotherapy, seven received radiotherapy alone and four received chemotherapy alone. The five-year RFS was 53%. Cryptorchidism did not adversely affect the survival of the patients. High level beta HCG was more commonly encountered in patients with an advanced disease 5/22 in stages IIb, IIc and III compared with 1/38 in stages I and IIa


Assuntos
Humanos , Masculino , Neoplasias Testiculares/cirurgia , Seminoma/tratamento farmacológico , Seminoma/radioterapia , Orquiectomia , Estadiamento de Neoplasias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA